Showing results (41-50 of 372) with videos related to
Sort By:
Pageof 38
Nature Reviews. Clinical Oncology|July 4, 2018
Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detectionChristopher Abbosh, Nicolai J Birkbak, Charles SwantonNature Reviews. Clinical Oncology|September 21, 2022
Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challengesImran Noorani, Paul S Mischel, Charles SwantonCancer Discovery|March 2, 2026
Transcriptomic Subtypes Are Associated with Clinical Outcomes for Patients with Lung Adenocarcinoma Who Have Never SmokedAlexander A Azizi, Tej Pandya, Charles SwantonCancer Discovery|June 13, 2024
Tumor Promoters and Opportunities for Molecular Cancer PreventionWilliam Hill, Clare E Weeden, Charles SwantonCancer Discovery|July 22, 2017
Tumor Evolution as a Therapeutic TargetNabil Amirouchene-Angelozzi, Charles Swanton, Alberto BardelliThe American Journal of Pathology|May 28, 2013
Adapting clinical paradigms to the challenges of cancer clonal evolutionNirupa Murugaesu, Su Kit Chew, Charles SwantonBiochemical Society Transactions|February 17, 2017
Constraints in cancer evolutionSubramanian Venkatesan, Nicolai J Birkbak, Charles SwantonNature Reviews. Genetics|March 11, 2025
Integrating model systems and genomic insights to decipher mechanisms of cancer metastasisMichelle M Leung, Charles Swanton, Nicholas McGranahanTrends in Cell Biology|August 17, 2021
Capturing cancer evolution using genetically engineered mouse models (GEMMs)William Hill, Deborah R Caswell, Charles SwantonJournal of the National Cancer Institute|August 12, 2025
The National Health Service-Galleri multi-cancer screening trial: explanation and justification of unique and important design issuesPeter Sasieni, Charles Swanton, Richard D NealPageof 38